API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.businesswire.com/news/home/20201229005039/en/Olatec-Therapeutics%E2%80%99-Lead-Compound-Dapansutrile-a-Selective-NLRP3-Inhibitor-Prevents-the-Inflammatory-Response-and-Restores-Cognitive-and-Behavioral-Deficits-in-a-Mouse-Model-of-Alzheimer%E2%80%99s-Disease